Literature DB >> 32732988

A recently described type 2 conventional dendritic cell (cDC2) subset mediates inflammation.

Jenn-Yeu Shin1, Chen-Yu Wang1, Chi-Chien Lin2, Ching-Liang Chu3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32732988      PMCID： PMC7785008          DOI： 10.1038/s41423-020-0511-y

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  3 in total

Review 1.  Dendritic cell vaccine therapy for colorectal cancer.

Authors:  Amanda L Wooster; Lydia H Girgis; Hayley Brazeale; Trevor S Anderson; Laurence M Wood; Devin B Lowe
Journal:  Pharmacol Res       Date:  2020-12-28       Impact factor: 7.658

2.  The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.

Authors:  Adriana Albini; Giovanni Di Guardo; Douglas McClain Noonan; Michele Lombardo
Journal:  Intern Emerg Med       Date:  2020-05-19       Impact factor: 3.397

Review 3.  Antigen transfer and its effect on vaccine-induced immune amplification and tolerance.

Authors:  Yingying Shi; Yichao Lu; Jian You
Journal:  Theranostics       Date:  2022-08-01       Impact factor: 11.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.